Meyka Pro banner
P3 Health Partners Inc.

P3 Health Partners Inc. (NASDAQ: PIIIW) Stock Competitors & Peer Comparison

See PIIIW's competitors and their performance on the NASDAQ and across the wider stock market.

PIIIWNASDAQ
IndustrialsSpecialty Business Services
$0.01
$0.002(9.43%)
U.S. Market opens in 48h 16m

Peer Comparison Table: Specialty Business Services Industry

Detailed financial metrics including price, market cap, P/E ratio, and more for PIIIW and its NASDAQ peers.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
PIIIW$0.01-9.43%29MN/A-$50.18N/A
CTAS$199.52-1.96%80.3B40.63$4.94+0.94%
RELX$34.43-0.69%60.1B20.16$1.71+1.57%
TRI$103.61-2.32%45.2B25.03$4.14+3.83%
CPRT$31.61+7.55%29.3B19.63$1.61N/A
ARMK$62.39+2.09%16.4B30.58$2.04+0.75%
RBA$84.26-2.49%15.7B20.15$4.18+1.47%
ULS$77.46+0.85%15.6B35.52$2.18+0.71%
BIPI$16.74-0.03%13.3BN/AN/A+7.64%
RTO$23.84-1.08%12B20.63$1.16+1.81%
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

Cintas Corporation (NASDAQ: CTAS)

PIIIW vs CTAS Comparison August 2026

P3 Health Partners Inc. (NASDAQ: PIIIW) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PIIIW stands at 29M. In comparison, CTAS has a market cap of 80.3B. Regarding current trading prices, PIIIW is priced at $0.01 on the NASDAQ, while CTAS trades at $199.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PIIIW currently has a P/E ratio of N/A, whereas CTAS's P/E ratio is 40.63. In terms of profitability, PIIIW's ROE is +1.61%, compared to CTAS's ROE of +0.42%. Regarding short-term risk, PIIIW is more volatile compared to CTAS. This indicates higher risk in terms of short-term price fluctuations for PIIIW.Check CTAS's competition here

Stock price comparison of stocks in the Industrials Sector

Loading...

Frequently Asked Questions